文献速递瓣膜外科

CardioCel心包补片行二尖瓣修复的初步经验与早期结果

Initial Experience and Early Results of Mitral Valve Repair With CardioCel Pericardial Patch.
PubMed 文献 · Ann Thorac Surg · 2018-06-07

本研究评估经组织工程处理的牛心包补片(CardioCel)在二尖瓣修复术中的表现,2014年3月至2016年4月共30例患者(年龄57.2±14.3岁,女性27%)接受CardioCel补片二尖瓣叶修复。围术期死亡7%(2例,非补片相关),平均随访1.7±0.9年,3例追加死亡(2例感染性心内膜炎、1例非心脏相关);随访超声(1.7±0.8年,28例院内存活者中26例[93%]可获取)显示2例复发反流(均为感染性心内膜炎),1例再手术(补片修复层面未见感染)。结论为初步结果满意,但抗感染及晚期退变需未来评估。

要点

  • 30例患者以CardioCel补片行二尖瓣叶修复,围术期死亡7%(2例,非补片相关)。
  • 平均随访1.7±0.9年,随访超声示2例复发反流(均为感染性心内膜炎),1例再手术。
  • 随访超声示补片厚度与回声密度与术后早期超声相当。

核心结论

  • CardioCel补片在二尖瓣修复术中的初步结果满意,但其抗感染能力与晚期退变尚需未来评估。

研究设计与样本

  • 2014年3月至2016年4月,30例患者(年龄57.2±14.3岁;女性27%)接受CardioCel补片二尖瓣叶修复。

主要发现

  • 围术期死亡7%(2例,非补片相关)。
  • 28例剩余患者出院前超声示修复瓣膜功能良好。
  • 平均随访1.7±0.9年,3例追加死亡(2例感染性心内膜炎、1例非心脏相关)。
  • 随访超声(随访时间1.7±0.8年;28例院内存活者中26例[93%]可获取)示2例复发反流(均为感染性心内膜炎),1例再手术(补片修复层面未见感染)。
  • 其余患者最近一次超声示无反流或轻度反流,跨瓣压差稳定;随访超声示补片厚度与回声密度与术后超声相当。

局限性

  • 原文结论指出补片的抗感染能力与晚期退变尚需未来评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The objective of this study was to assess the performance of a tissue engineering process-treated bovine pericardium patch (CardioCel, Admedus Regen Pty Ltd, Perth, Australia) in the setting of reconstructive mitral valve surgical procedures. DESCRIPTION: Between March 2014 and April 2016, 30 patients (57.2 ± 14.3 years of age; 27% female) underwent mitral valve leaflet repair with a CardioCel patch. EVALUATION: Perioperative mortality was 7% (2 patients, non-graft related). In the 28 remaining patients, predischarge echocardiography demonstrated good repaired valve function. At a mean follow-up of 1.7 ± 0.9 years, three additional deaths occurred (two resulting from infective endocarditis and one non-cardiac related). On follow-up echocardiography (follow-up time of 1.7 ± 0.8 years; available for 26 of 28 [93%] hospital survivors), recurrent regurgitation was seen in 2 patients (both with infective endocarditis), and 1 patient underwent reoperation (no infection at the level of patch repair was observed). In the remaining patients, the most recent echocardiogram demonstrated no regurgitation or mild regurgitation and stable gradients. The thickness and echodensity of the implanted patch on follow-up echocardiograms were comparable with postoperative echocardiograms. CONCLUSIONS: Initial results with the CardioCel patch in mitral valve repair operations were satisfactory. The resistance to infection and late degeneration will need to be assessed in the future.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tomšič A, Bissessar DD, van Brakel TJ, et al. Initial Experience and Early Results of Mitral Valve Repair With CardioCel Pericardial Patch. Ann Thorac Surg. 2018. PMID: 29885979. doi:10.1016/j.athoracsur.2018.04.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。